Literature DB >> 22468615

Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.

Inês Ribeiro-Vaz1, Cristina Santos, Altamiro da Costa-Pereira, Ricardo Cruz-Correia.   

Abstract

BACKGROUND: Spontaneous adverse drug reaction (ADR) reporting has been described as an efficient method to detect drug safety signals. However, under-reporting is a major issue undermining the effectiveness of spontaneous reports. Among hospitalized patients, ADRs are a particularly serious problem because these patients are often treated with more than one drug, and these drugs are often new and aggressive.
OBJECTIVE: To promote spontaneous ADR reporting by healthcare professionals working in hospitals in the northern regions of Portugal, we propose the inclusion of a hyperlink to an online ADR reporting form on hospitals' electronic patient records (EPRs). The main aim of this study was to evaluate the impact of these hyperlinks on the number of spontaneous ADR reports to the Northern Pharmacovigilance Centre (UFN - Unidade de Farmacovigilância do Norte). We also assess the number of daily UFN website visits before and after the inclusion of the hyperlinks.
METHODS: An ecological study was performed in northern Portuguese hospitals from 2006 to 2010. The hyperlinks were included in either EPRs or on computer desktops. The median of spontaneous ADR reports (total and online) per month and the respective ranges were presented before and after the intervention in all hospitals in this study. The comparisons were performed using the Mann-Whitney U-test.
RESULTS: Sixteen hospital centres were involved in the study (27 hospitals). Eleven centres (18 hospitals) included the hyperlinks. Considering the hospitals with hyperlink access to the EPRs, the median ADR reports per month significantly increased, from two (range 0-12) to five reports (range 1-17). The median of ADR reports per month using the online form also increased significantly, from one (range 0-5) before the intervention to four (range 1-17) after it. Moreover, serious ADRs increased 3-fold, and non-previously described ADRs increased 4.5-fold. None of these significant increases were observed in the hospitals where the hyperlink was not installed. We also found a significant increase in daily UFN website visits, from ten before the intervention to 27 after it (p < 0.001).
CONCLUSION: The increase in ADR reporting shows that the inclusion of hyperlinks to online ADR reporting forms is an easy and cost-effective way to change health professional behaviours with regard to spontaneous ADR reports.

Entities:  

Mesh:

Year:  2012        PMID: 22468615     DOI: 10.2165/11597190-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  11 in total

1.  Timing of new black box warnings and withdrawals for prescription medications.

Authors:  Karen E Lasser; Paul D Allen; Steffie J Woolhandler; David U Himmelstein; Sidney M Wolfe; David H Bor
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

Review 2.  Detecting adverse events using information technology.

Authors:  David W Bates; R Scott Evans; Harvey Murff; Peter D Stetson; Lisa Pizziferri; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2003 Mar-Apr       Impact factor: 4.497

3.  Computerized surveillance of adverse drug events in hospital patients. 1991.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  Qual Saf Health Care       Date:  2005-06

4.  An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.

Authors:  Adolfo Figueiras; Maria T Herdeiro; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  JAMA       Date:  2006-09-06       Impact factor: 56.272

5.  An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.

Authors:  Consuelo Pedrós; Antoni Vallano; Gloria Cereza; Gemma Mendoza-Aran; Antònia Agustí; Cristina Aguilera; Immaculada Danés; Xavier Vidal; Josep M Arnau
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.

Authors:  C C Smith; P M Bennett; H M Pearce; P I Harrison; D J Reynolds; J K Aronson; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1996-10       Impact factor: 4.335

7.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

8.  Reporting of adverse drug reactions by hospital doctors and the response to intervention.

Authors:  P McGettigan; J Golden; R M Conroy; N Arthur; J Feely
Journal:  Br J Clin Pharmacol       Date:  1997-07       Impact factor: 4.335

9.  Description of a computerized adverse drug event monitor using a hospital information system.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  Hosp Pharm       Date:  1992-09

10.  Drug safety information through the internet: the experience of an Italian website.

Authors:  Giovanni Polimeni; Alessandra Russo; Maria Antonietta Catania; Andrea Aiello; Alessandro Oteri; Gianluca Trifirò; Gioacchino Calapai; Lidia Sautebin; Massimo Iacobelli; Achille P Caputi
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

View more
  11 in total

1.  Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation.

Authors:  Oscar O Agoro; Sarah W Kibira; Jenny V Freeman; Hamish S F Fraser
Journal:  J Am Med Inform Assoc       Date:  2018-06-01       Impact factor: 4.497

Review 2.  The effects of on-screen, point of care computer reminders on processes and outcomes of care.

Authors:  Kaveh G Shojania; Alison Jennings; Alain Mayhew; Craig R Ramsay; Martin P Eccles; Jeremy Grimshaw
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

3.  Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting.

Authors:  Thierry Trenque; Géric Maura; Emmanuelle Herlem; Catherine Vallet; Elodie Sole; Pascal Auriche; Moustapha Drame
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

4.  A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.

Authors:  Olga Morales Ríos; Luis Jasso Gutiérrez; Juan O Talavera; Martha María Téllez-Rojo; Víctor Olivar López; Juan Garduño Espinosa; Onofre Muñoz Hernández
Journal:  Int J Clin Pharm       Date:  2016-02

Review 5.  How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.

Authors:  Inês Ribeiro-Vaz; Ana-Marta Silva; Cristina Costa Santos; Ricardo Cruz-Correia
Journal:  BMC Med Inform Decis Mak       Date:  2016-03-01       Impact factor: 2.796

6.  A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.

Authors:  Hisham Aljadhey; Mansour A Mahmoud; Thamir M Alshammari; Mohammed Al-Dhaeefi; Herve Le Louet; Susana Perez-Gutthann; Peter J Pitts
Journal:  Saudi Med J       Date:  2015-09       Impact factor: 1.484

7.  Promoting adverse drug reaction reporting: comparison of different approaches.

Authors:  Inês Ribeiro-Vaz; Cristina Costa Santos; Ricardo Cruz-Correia
Journal:  Rev Saude Publica       Date:  2016-05-03       Impact factor: 2.106

8.  Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?

Authors:  Pramod Kumar Sharma; Surjit Singh; Puneet Dhamija
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun

Review 9.  Patient Participation and the Use of Ehealth Tools for Pharmacoviligance.

Authors:  Joëlle Berrewaerts; Laure Delbecque; Pierre Orban; Martin Desseilles
Journal:  Front Pharmacol       Date:  2016-04-11       Impact factor: 5.810

10.  Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district.

Authors:  H M Haines; J C Meyer; R S Summers; B B Godman
Journal:  Eur J Clin Pharmacol       Date:  2020-04-15       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.